Parkman Healthcare Partners’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-15,236
Closed -$1.25M 90
2022
Q1
$1.25M Buy
15,236
+2,322
+18% +$191K 0.37% 61
2021
Q4
$1.89M Buy
+12,914
New +$1.89M 0.42% 61